Suppr超能文献

酮洛芬和保泰松对马慢性蹄痛和跛行的影响。

Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse.

作者信息

Owens J G, Kamerling S G, Stanton S R, Keowen M L

机构信息

Department of Veterinary Physiology, Pharmacology and Toxicology, School of Veterinary Medicine, Louisiana State University, Baton Rouge 70803, USA.

出版信息

Equine Vet J. 1995 Jul;27(4):296-300. doi: 10.1111/j.2042-3306.1995.tb03080.x.

Abstract

The analgesic effects of the nonsteroidal anti-inflammatory drugs, ketoprofen (2.2 and 3.63 mg/kg bwt) and phenylbutazone (4.4 mg/kg bwt) were compared in 7 horses with chronic laminitis. Hoof pain was quantified objectively by means of an electronic hoof tester and lameness was subjectively graded on a modified Obel scale. Ketoprofen at a dose of 3.63 mg/kg bwt (phenylbutazone equimolar dose) reduced hoof pain and lameness to a greater extent than the 2.2 mg/kg dose and phenylbutazone. These effects were still present at 24 h in 3 of the 4 pain tests, including lameness grade. These data suggest that ketoprofen at the dosage rate of 1.65 times the recommended therapeutic dose was more potent than phenylbutazone in alleviating chronic pain and lameness in horses.

摘要

在7匹患有慢性蹄叶炎的马中,比较了非甾体抗炎药酮洛芬(2.2毫克/千克体重和3.63毫克/千克体重)和保泰松(4.4毫克/千克体重)的镇痛效果。通过电子蹄测试仪客观地量化蹄部疼痛,并根据改良的奥贝尔量表主观地对跛行进行分级。剂量为3.63毫克/千克体重(与保泰松等摩尔剂量)的酮洛芬比2.2毫克/千克剂量的酮洛芬和保泰松在更大程度上减轻了蹄部疼痛和跛行。在4项疼痛测试中的3项(包括跛行分级)中,这些效果在24小时时仍然存在。这些数据表明,剂量为推荐治疗剂量1.65倍的酮洛芬在减轻马的慢性疼痛和跛行方面比保泰松更有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验